Literature DB >> 9624238

Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers.

I de Mascarel1, F Bonichon, M Durand, L Mauriac, G MacGrogan, I Soubeyran, V Picot, A Avril, J M Coindre, M Trojani.   

Abstract

This study was conducted to determine the prognostic influence of obvious peritumoral vascular emboli as prospectively determined by a simple routine slide examination in patients with operable node-negative breast cancer. Obvious peritumoral emboli (OPE) were defined by the presence of neoplastic emboli within unequivocal vascular lumina (including both lymphatic spaces and blood capillaries) in areas adjacent to but outside the margins of the carcinoma. OPE were assessed routinely on 5 microns thick haematoxylin and eosin-stained sections for each of 1320 primary operable node-negative breast cancers from 1975 to 1992 at our institution. OPE and other prognostic variables (tumour size, SBR grade, oestrogen and progesterone receptor status) were correlated to overall survival (OS) and metastasis-free interval (MFI) by means of univariate and multivariate analysis with a median follow-up of 103 months. OPE were found in 19.5% of tumours. In univariate analysis, OPE were related to tumour size (P = 6.3 x 10(-5)) and histologic grade (P = 4.9 x 10(-7)). Statistically significant correlations were found with OS (P = 4.6 x 10(-5)) and MFI (P = 6.4 x 10(-9)). Furthermore, in multivariate analysis, OPE was an independent prognostic variable, the most predictive factor for MFI (P = 7.7 x 10(-7)) before tumour size and grade, and was second after tumour grade for OS (P = 0.002). This study on a large unicentric series and with a long follow-up confirms the prognostic significance of vascular emboli in patients with operable node-negative breast carcinoma. Importantly, vascular emboli were found to be accurately detectable by a simple routine and non-time-consuming method. Therefore, such obvious vascular emboli should be considered as an important cost-effective, prognostic variable in patients with node-negative breast carcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9624238     DOI: 10.1016/s0959-8049(97)00344-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  23 in total

1.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

2.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

3.  Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.

Authors:  Sarah B Fisher; Sameer H Patel; David A Kooby; Sharon Weber; Mark Bloomston; Clifford Cho; Ioannis Hatzaras; Carl Schmidt; Emily Winslow; Charles A Staley; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2012-05-22       Impact factor: 3.647

4.  Improved breast cancer prognosis through the combination of clinical and genetic markers.

Authors:  Yijun Sun; Steve Goodison; Jian Li; Li Liu; William Farmerie
Journal:  Bioinformatics       Date:  2006-11-26       Impact factor: 6.937

5.  Correlation between mammographic and sonographic findings and prognostic factors in patients with node-negative invasive breast cancer.

Authors:  H J Shin; H H Kim; M O Huh; M J Kim; A Yi; H Kim; B H Son; S H Ahn
Journal:  Br J Radiol       Date:  2010-08-03       Impact factor: 3.039

6.  Apparent diffusion coefficient value in invasive ductal carcinoma at 3.0 Tesla: is it correlated with prognostic factors?

Authors:  Inanc Guvenc; Sinan Akay; Selami Ince; Ramazan Yildiz; Zafer Kilbas; Fahrettin G Oysul; Mustafa Tasar
Journal:  Br J Radiol       Date:  2016-02-08       Impact factor: 3.039

7.  Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer.

Authors:  Naoko Mori; Shunji Mugikura; Chiaki Takasawa; Minoru Miyashita; Akiko Shimauchi; Hideki Ota; Takanori Ishida; Atsuko kasajima; Kei Takase; Tetsuya Kodama; Shoki Takahashi
Journal:  Eur Radiol       Date:  2015-05-30       Impact factor: 5.315

8.  Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis.

Authors:  P J Westenend; C J C Meurs; R A M Damhuis
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

Review 9.  The Nottingham prognostic index for invasive carcinoma of the breast.

Authors:  Andrew H S Lee; Ian O Ellis
Journal:  Pathol Oncol Res       Date:  2008-06-10       Impact factor: 3.201

Review 10.  Prognostic and predictive factors and genetic analysis of early breast cancer.

Authors:  Miguel Martín; Fernando González Palacios; Javier Cortés; Juan de la Haba; José Schneider
Journal:  Clin Transl Oncol       Date:  2009-10       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.